[1] |
Döhner H, Weisdorf DJ, Bloomfield CD. Acute myeloid leukemia[J]. N Engl J Med, 2015, 373: 1136-1152.
|
[2] |
DiNardo CD, Erba HP, Freeman SD, et al. Acute myeloid leukaemia[J]. Lancet, 2023, 401: 2073-2086.
|
[3] |
Harada K, Mizuno S, Yano S, et al. Donor lymphocyte infusion after haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia[J]. Ann Hematol, 2022, 101: 643-653.
|
[4] |
Li Y, Li B, Xu Y, et al. GOT2 silencing promotes reprogramming of glutamine metabolism and sensitizes hepatocellular carcinoma to glutaminase inhibitors[J]. Cancer Res, 2022, 82: 3223-3235.
|
[5] |
Sun X, Wu B, Chiang HC, et al. Tumour DDR1 promotes collagen fibre alignment to instigate immune exclusion[J]. Nature, 2021, 599: 673-678.
|
[6] |
Abrego J, Sanford-Crane H, Oon C, et al. A cancer cell-intrinsic GOT2-PPARδ axis suppresses antitumor immunity[J]. Cancer Discov, 2022, 12: 2414-2433.
|
[7] |
Hanahan D. Hallmarks of cancer: new dimensions[J]. Cancer Discov, 2022, 12: 31-46.
|
[8] |
Stevens BM, Jones CL, Pollyea DA, et al. Fatty acid metabolism underlies venetoclax resistance in acute myeloid leukemia stem cells[J]. Nat Cancer, 2020, 1: 1176-1187.
|
[9] |
Mishra SK, Millman SE, Zhang L. Metabolism in acute myeloid leukemia: mechanistic insights and therapeutic targets[J]. Blood, 2023, 141: 1119-1135.
|
[10] |
Williams RT, Guarecuco R, Gates LA, et al. ZBTB1 regulates asparagine synthesis and leukemia cell response to L-asparaginase[J]. Cell Metab, 2020, 31: 852-861.
|
[11] |
Holeček M. Aspartic acid in health and disease[J]. Nutrients, 2023, 15: 4023. doi: 10.3390/nu15184023.
|
[12] |
Qi L, Martin-Sandoval MS, Merchant S, et al. Aspartate availability limits hematopoietic stem cell function during hematopoietic regeneration[J]. Cell Stem Cell, 2021, 28: 1982-1999.
|
[13] |
Stuani L, Sarry JE. Microenvironmental aspartate preserves leukemic cells from therapy-induced metabolic collapse[J]. Cell Metab, 2020, 32: 321-323.
|
[14] |
Lu MJ, Busquets J, Impedovo V, et al. SLC25A51 decouples the mitochondrial NAD+/NADH ratio to control proliferation of AML cells[J]. Cell Metab, 2024, 36: 808-821.
|